يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Svajda L"', وقت الاستعلام: 0.97s تنقيح النتائج
  1. 1
    دورية أكاديمية
    CDK9 inhibition as an effective therapy for small cell lung cancer

    المؤلفون: Valdez Capuccino, L.Aff1, Aff2, Aff3, Kleitke, T.Aff1, Aff2, Aff3, Szokol, B., Svajda, L., Martin, F.Aff6, Aff7, Aff8, Bonechi, F.Aff1, Aff2, Aff3, Krekó, M.Aff4, Aff9, Azami, S.Aff1, Aff2, Aff3, Montinaro, A., Wang, Y.Aff1, Aff2, Aff3, Nikolov, V.Aff3, Aff11, Kaiser, L., Bonasera, D.Aff2, Aff11, Aff12, Saggau, J.Aff2, Aff11, Aff12, Scholz, T.Aff1, Aff2, Schmitt, A., Beleggia, F.Aff1, Aff13, Aff14, Reinhardt, H. C., George, J.Aff1, Aff16, Liccardi, G.Aff2, Aff12, Walczak, H.Aff3, Aff10, Aff11, Tóvári, J., Brägelmann, J.Aff1, Aff2, Aff14, Montero, J.Aff6, Aff7, Aff8, Sos, M. L.Aff1, Aff17, Őrfi, L.Aff4, Aff9, Peltzer, N.Aff1, Aff2, Aff3, IDs41419024067244_cor27

    المصدر: Cell Death & Disease. 15(5)

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View this record from ISI Web of Science
    أضف إلى المفضلة
  3. 3
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View record in Scopus
    أضف إلى المفضلة
  4. 4
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View record in Scopus
    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Differential effects of hypoxia on motility using various in vitro models of lung adenocarcinoma.

    المؤلفون: Surguta SE; Department of Experimental Pharmacology and the National Tumor Biology Laboratory, National Institute of Oncology, Budapest, 1122, Hungary. surguta.sara@ext.oncol.hu.; School of Ph.D. Studies, Semmelweis University, Budapest, 1085, Hungary. surguta.sara@ext.oncol.hu., Baranyi M; Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, 1091, Hungary., Svajda L; Department of Experimental Pharmacology and the National Tumor Biology Laboratory, National Institute of Oncology, Budapest, 1122, Hungary.; School of Ph.D. Studies, Semmelweis University, Budapest, 1085, Hungary., Cserepes M; Department of Experimental Pharmacology and the National Tumor Biology Laboratory, National Institute of Oncology, Budapest, 1122, Hungary., Ranđelović I; Department of Experimental Pharmacology and the National Tumor Biology Laboratory, National Institute of Oncology, Budapest, 1122, Hungary., Tátrai E; Department of Experimental Pharmacology and the National Tumor Biology Laboratory, National Institute of Oncology, Budapest, 1122, Hungary., Hegedűs B; Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, 1091, Hungary.; Department of Thoracic Surgery, University Medicine Essen - Ruhrlandklinik, University Duisburg-Essen, 45239, Essen, Germany., Tóvári J; Department of Experimental Pharmacology and the National Tumor Biology Laboratory, National Institute of Oncology, Budapest, 1122, Hungary.; School of Ph.D. Studies, Semmelweis University, Budapest, 1085, Hungary.

    المصدر: Scientific reports [Sci Rep] 2024 Sep 03; Vol. 14 (1), pp. 20482. Date of Electronic Publication: 2024 Sep 03.

    نوع المنشور: Journal Article

    بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

    مواضيع طبية MeSH: Cell Movement* , Adenocarcinoma of Lung*/pathology , Adenocarcinoma of Lung*/genetics , Adenocarcinoma of Lung*/metabolism , Cell Proliferation* , Epithelial-Mesenchymal Transition* , Lung Neoplasms*/pathology , Lung Neoplasms*/metabolism , Lung Neoplasms*/genetics, Humans ; Cell Line, Tumor ; Apoptosis ; Cell Hypoxia ; Gene Expression Regulation, Neoplastic ; A549 Cells

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    [Immunomodulation in the tumor microenvironment: Therapeutic potential of combined inhibition of tumor hypoxia and PD-1/ PD-L1].

    عنوان ترانسليتريتد: Immunmoduláció a tumor mikrokörnyezetében: a tumorhipoxia és a PD-1/PD-L1 együttes gátlásának terápiás lehetőségei.

    المؤلفون: Svajda L; Kísérletes Farmakológiai Osztály, Országos Onkológiai Intézet, Budapest, Hungary. svajda.laura@ext.oncol.hu., Cserepes M; Kísérletes Farmakológiai Osztály, Országos Onkológiai Intézet, Budapest, Hungary. svajda.laura@ext.oncol.hu., Hegyi B; Nemzeti Tumorbiológiai Laboratórium, Országos Onkológiai Intézet, Budapest, Hungary., Niczky T; Kísérletes Farmakológiai Osztály, Országos Onkológiai Intézet, Budapest, Hungary. svajda.laura@ext.oncol.hu., Tóvári J; Kísérletes Farmakológiai Osztály, Országos Onkológiai Intézet, Budapest, Hungary. svajda.laura@ext.oncol.hu.

    المصدر: Magyar onkologia [Magy Onkol] 2024 Jul 16; Vol. 68 (2), pp. 126-135. Date of Electronic Publication: 2024 Jun 03.

    نوع المنشور: Journal Article; Review; English Abstract

    بيانات الدورية: Publisher: Professional Publishing Hungary Kft Country of Publication: Hungary NLM ID: 9313833 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2060-0399 (Electronic) Linking ISSN: 00250244 NLM ISO Abbreviation: Magy Onkol Subsets: MEDLINE

    مواضيع طبية MeSH: Tumor Microenvironment*/immunology , Tumor Microenvironment*/drug effects , B7-H1 Antigen*/antagonists & inhibitors , B7-H1 Antigen*/metabolism , Neoplasms*/immunology , Neoplasms*/drug therapy , Neoplasms*/pathology , Tumor Hypoxia*/drug effects , Programmed Cell Death 1 Receptor*/antagonists & inhibitors, Humans ; Signal Transduction/drug effects ; Hypoxia-Inducible Factor 1, alpha Subunit/metabolism

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء